Chlamydia screening - Australia should strive to achieve what others have not

Medical Journal of Australia

Volumn 188, Issue 2, 2008, Pages 106-108

  Hocking, Jane S ^a   Walker, Jennifer ^a   Regan, David ^b   Chen, Marcus Y ^a,c   Fairley, Christopher K ^a,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c MELBOURNE SEXUAL HEALTH CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUSTRALIA; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL TRIAL; GENERAL PRACTICE; HIGH RISK BEHAVIOR; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION PREVENTION; MATHEMATICAL MODEL; MORBIDITY; PAPANICOLAOU TEST; PELVIC INFLAMMATORY DISEASE; PREVALENCE; PRIMARY HEALTH CARE; SCREENING TEST; SEXUAL BEHAVIOR; BIOLOGICAL MODEL; FEMALE; MASS SCREENING; VAGINA SMEAR;

AUSTRALIA; CHLAMYDIA INFECTIONS; FAMILY PRACTICE; FEMALE; HUMANS; MASS SCREENING; MODELS, BIOLOGICAL; SEXUAL BEHAVIOR; VAGINAL SMEARS;

EID: 41149165166     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2008.tb01533.x     Document Type: Article

References (35)

1. Australian Government Department of Health and Ageing. National Notifiable Diseases Surveillance System. Number of notifications of chlamydial infection, Australia, 2005 by age group and sex. Canberra: DoHA, 2005. http://www9.health.gov.au/cda/Source/Rpt_5.cfm (accessed Jul 2007).
2. Peipert JF. Genital chlamydial infections. N Engl J Med 2003; 349: 2424-2430.
3. Sutton T, Martinko T, Hale S, Fairchok MP. Prevalence and high rate of asymptomatic infection of Chlamydia trachomatis in male college reserve officer training corps cadets. Sex Transm Dis 2003; 30: 901-904.
4. Morré SA, van Valkengoed IGM, de Jong A, et al. Mailed, home-obtained urine specimens: a reliable screening approach for detecting asymptomatic Chlamydia trachomatis infections. J Clin Microbiol 1999; 37: 976-980.
5. Magid D, Douglas JM, Schwartz JS. Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: an incremental cost-effectiveness analysis. Ann Intern Med 1996; 124: 389-399.
6. Australian Government Department of Health and Ageing. National Sexually Transmissible Infections Strategy 2005-2008. Canberra: DoHA, 2005. http://www.health.gov.au/internet/wcms/publishing.nsf/Content/ phd-sti-strategycnt.htm/$FILE/sti_strategy.pdf (accessed Jul 2007).
7. Abbott T. Pilot testing program for chlamydia. Media release ABB078/05, 27 Jun 2005. Canberra: Australian Government Department of Health and Ageing, 2005. http://www.health.gov.au/internet/ministers/publishing.nsf/ Content/health-mediarel-yr2005-ta-abb078.htm?OpenDocument&yr= 2005&mth=6 (accessed Jul 2007).
8. Abbott T. Chlamydia projects to target high-risk groups. Media release ABB115/06, 8 Aug 2006. Canberra: Australian Government Department of Health and Ageing, 2006. http://www.health.gov.au/internet/ministers/ publishing.nsf/Content/health-mediarel-yr2006-ta- abb115.htm?OpenDocument&yr=2006&mth=8 (accessed Jul 2007).
9. Australian Government Department of Health and Ageing. The design, modelling and evaluation of the Chlamydia Pilot in General Practice. Request for tender. Canberra: DoHA, 2007. https://www.tenders.gov.au/ ?event=public.advert.showClosed&AdvertUUID=0F156190-F5E5-8ADC- 9AC38D8C78C25DAE (accessed Nov 2007).
10. Low N. Current status of chlamydia screening in Europe. Eurosurveillance 2004; 9(10-12): 68-70. http://www.eurosurveillance.org/eq/2004/04-04/pdf/eq_10_2004_68-70.pdf (accessed Nov 2007).
11. Hillis SD, Nakashima A, Amsterdam L, et al. The impact of a comprehensive chlamydia prevention program in Wisconsin. Fam Plann Perspect 1995; 27: 108-111.
12. Herrmann B, Egger M. Genital Chlamydia trachomatis infections in Uppsala County, Sweden, 1985-1993: declining rates for how much longer? Sex Transm Dis 1995; 22: 253-260.
13. Smittskyddsinstitutet [Swedish Institute for Infectious Disease Control]. Epidemiologisk årsrapport 2005. Solna: Smittskyddsinstitutet, 2006. http://www.smittskyddsinstitutet.se/upload/ Publikationer/SMI-epidemiologiskarsrapport-2005.pdf (accessed Nov 2007).
14. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2004 supplement. Chlamydia prevalence monitoring project annual report 2004. Atlanta, Ga: Department of Health and Human Services, Centres for Disease Control and Prevention, 2005. http://www.cdc.gov/std/Chlamydia2004/ctsupplement_2004FINAL.pdf (accessed Jul 2007).
15. Statens Serum Institut [State Serum Institute]. Epi-News: national surveillance of communicable diseases. Copenhagen: Statens Serum Institut, 2005. http://www.ssi.dk/sw34485.asp (accessed Jul 2007).
16. Scholes D, Stergachis A, Heidrich FE, et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996; 334: 1362-1366.
17. Ostergaard L, Andersen B, Møller JK, Olesen F. Home sampling versus conventional swab sampling for screening of Chlamydia trachomatis in women: a cluster-randomised 1-year follow-up study. Clin Infect Dis 2000; 31: 951-957.
18. Low N, Egger M. What should we do about screening for genital chlamydia? Int J Epidemiol 2002; 31: 891-893.
19. Egger M, Low N, Smith GD, et al. Screening for chlamydia infections and the risk of ectopic pregnancy in a county in Sweden: ecological analysis. BMJ 1998; 316: 1776-1780.
20. Kretzschmar K, Welte R, van den Hoek A, Postma MJ. Comparative model-based analysis of screening programs for Chlamydia trachomatis infections. Am J Epidemiol 2001; 153: 90-101.
21. Turner K, Adams E, LaMontagne D, et al. Modelling the effectiveness of chlamydia screening in England. Sex Transm Infect 2006; 82: 496-502.
22. Götz H, Lindbäck J, Ripa T, et al. Is the increase in notifications of Chlamydia trachomatis infections in Sweden the result of changes in prevalence, sampling frequency or diagnostic methods? Scand J Infect Dis 2002; 34: 28-34.
23. Nicoll A, Hughes G, Connelly M, et al. Assessing the impact of national anti-HIV sexual health campaigns: trends in the transmission of HIV and other sexually transmitted infections in England. Sex Transm Infect 2001; 77: 242-247.
24. Johnson AM, Mercer CH, Erens B, et al. Sexual behaviour in Britain: partnerships, practices and HIV risk behaviours. Lancet 2001; 358: 1835-1842.
25. Rissel CE, Richters J, Grulich AE, et al. Sex in Australia: first experiences of vaginal intercourse and oral sex among a representative sample of adults. Aust N Z J Public Health 2003; 27: 131-137.
26. Mitchell H. Cervical screening in Australia - changing from opportunistic to organised. Health Care Inform Rev Online [Internet] 2000; 4 (7). http://hcro.enigma.co.nz/website/ index.cfm?fuseaction=articledisplay&FeatureID=112 (accessed Jul 2007).
27. Wain GV. Cervical cancer prevention: the saga goes on, but so much has changed [editorial]! Med J Aust 2006; 185: 476-477.
28. Bowden FJ, Currie MJ, Toyne H, et al. Screening for Chlamydia trachomatis at the time of routine Pap smear in general practice: a cluster randomised controlled trial. Med J Aust 2008; 188: 76-80.
29. Medicare Australia. General Practice Immunisation Incentives (GPII) Scheme. http://www.medicareaustralia.gov.au/providers/ incentives_allowances/gpii_scheme.shtml (accessed Nov 2007).
30. Health Insurance Commission. General practice immunisation incentives - 2002/2003 statistical report. Canberra: HIC, 2003.
31. Health Insurance Commission. Practice Incentive Program (PIP). http://www.medicareaustralia.gov.au/providers/incentives_allowances/ pip.htm (accessed Apr 2007).
32. McInnes DK, Saltman DC, Kidd MR. General practitioners' use of computers for prescribing and electronic health records: results from a national survey. Med J Aust 2006; 185: 88-91.
33. Gold J, Hocking J, Hellard M. The feasibility of recruiting young men in rural areas from community football clubs for STI screening. Aust N Z J Public Health 2007; 31: 243-246.
34. Hocking J, Willis J, Tabrizi S, et al. A chlamydia prevalence survey of young women living in Melbourne, Victoria. Sex Health 2006; 3: 235-240.
35. Macleod J, Salisbury C, Low N, et al. Coverage and uptake of systematic postal screening for genital Chlamydia trachomatis and prevalence of infection in the United Kingdom general population: cross sectional study. BMJ 2005; 330: 940-943.